Investing Profile

Nancy Hong

InvestorVC
Managing Director at RiverVest Venture Partners
Photo of Nancy Hong, Managing Director at RiverVest

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
RiverVest Managing Director
$100K - $10.0M
$1M
9
$184.4M
CompanyStageDateRound SizeTotal Raised
Biolinq
Series CApr 2025$100M
Series BNov 2021$100M
$210M
Co-investors: Katie Ellias (T1D Fund)
Bluejay Therapeutics
Series CMay 2024$180M
Series BAug 2022$41M
$220M
Co-investors: Daniel Estes (Frazier Healthcare Partners)
Scout Bio
Series BOct 2021$33M
Series BMar 2019$20M
$53M
Co-investors: Cindy Cole (Digitalis Ventures)
SeQure Dx
Series AApr 2021$18M
$18M
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Peter Dudek (MRL Ventures Fund), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Andrew Hack (Bain Capital Life Sciences), Jack Kenney (SV Health Investors)